Literature DB >> 3120591

Treatment of experimental intravitreal fibrin with tissue plasminogen activator.

F H Lambrou1, R W Snyder, G A Williams, M Lewandowski.   

Abstract

We produced experimental intravitreal fibrin clots in rabbits that had previous gas compression of the vitreous or intact vitreous. Twenty-four hours after production of fibrin, the eyes were injected with 25 micrograms of tissue plasminogen activator or physiologic irrigation solution. In the gas compression group (n = 11), all tissue plasminogen activator-treated eyes cleared within six hours of injection; complete clearing was not seen until six days in the physiologic irrigation solution-treated eyes (n = 9). A similar response was seen in the intact vitreous group. No evidence of toxicity was observed as measured by slit-lamp biomicroscopy, intraocular pressure, corneal thickness, electroretinography, or histopathologic examination.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3120591     DOI: 10.1016/0002-9394(87)90175-9

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  6 in total

1.  Intravitreal recombinant tissue plasminogen activator in the treatment of experimentally induced bacterial endophthalmitis.

Authors:  N Baziuk; T Fang; G A Peyman; C M Gremillion
Journal:  Int Ophthalmol       Date:  1991-03       Impact factor: 2.031

2.  Plasminogen in proliferative vitreoretinal disorders.

Authors:  P Esser; K Heimann; K U Bartz-Schmidt; P Walter; R Krott; M Weller
Journal:  Br J Ophthalmol       Date:  1997-07       Impact factor: 4.638

3.  Treatment of experimental suprachoroidal hemorrhage with intravenous tissue plasminogen activator.

Authors:  J C Liu; G A Peyman; M Oncel
Journal:  Int Ophthalmol       Date:  1990-07       Impact factor: 2.031

Review 4.  Factors affecting the efficacy of antibiotics in the treatment of experimental postoperative endophthalmitis.

Authors:  G A Stern
Journal:  Trans Am Ophthalmol Soc       Date:  1993

5.  Corneal endothelial permeability in protection glaucoma filter bleb with tissue plasminogen activator.

Authors:  A Szymanski; A Gierek-Lapinska; M Koziak; S Gierek-Kalicka
Journal:  Int Ophthalmol       Date:  1995       Impact factor: 2.031

6.  Subconjunctival hemorrhage: risk factors and potential indicators.

Authors:  Bercin Tarlan; Hayyam Kiratli
Journal:  Clin Ophthalmol       Date:  2013-06-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.